Diamond Therapeutics Supports Health Canada Decision to Make

/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental...

Related Keywords

United States , Canada , Toronto , Ontario , American , Canadians , Canadian , Judy Blumstock , Diamond Therapeutics Inc , Dalton Pharma Services , Health Canada , Access Program , Diamond Therapeutics , Special Access Program , Health Canada Approved , Pharma Services , North American , Accelerated Stability Testing , Health Care Amp Hospitals , Mental Health , Supplementary Medicine , Medical Pharmaceuticals , International Medical Approval ,